Biocare Lifesciences opens new Makati office, deepens Indo–Philippine healthcare ties

Group photo of employees from Biocare, including a woman in a red sari and a man with a sunflower, standing in front of the Biocare logo.

Philippine pharmaceutical distributor Biocare Lifesciences, Inc. has formally inaugurated its new corporate office at Centuria Medical Makati, marking a strategic expansion that underscores the growing healthcare collaboration between the Philippines and India.

The two-day inauguration on February 24–25 was led by Harsh Kumar Jain, Ambassador of the Republic of India to the Philippines, alongside his spouse Smt. Vandana Jain and Biocare Managing Director Dileep Tiwari.

The ceremony gathered company executives, healthcare partners, and members of the business community in what executives described as both a corporate milestone and a reaffirmation of bilateral cooperation in healthcare.

In his remarks, Ambassador Jain emphasized Biocare’s role in broadening access to high-quality, affordable medicines sourced from more than 50 Indian pharmaceutical manufacturers.

He noted that the company’s operations represent a practical, patient-focused extension of Indo–Philippine relations—translating diplomatic goodwill into tangible health outcomes for Filipino communities.

Founded in 2011, Biocare Lifesciences began with a defined mandate: to support the country’s healthcare requirements through responsible importation, product registration, nationwide distribution, and ethical marketing.

Within five years, the company had built a distribution network serving both national and multinational partners—an early indicator of its operational scalability and disciplined compliance framework.

Today, Biocare’s portfolio spans multiple therapeutic categories, including anti-infectives, pediatrics, nephrology, urology, pulmonology, oncology, and anesthesia.

The company works with manufacturers operating facilities aligned with globally recognized regulatory standards such as PIC/S, EU, TGA, MHRA, and USFDA benchmarks—strengthening confidence among institutional buyers and healthcare providers.

The company’s commercial footprint has expanded steadily. In a 2023 report, Managing Director Tiwari disclosed that Biocare supplies affordable generic medicines to more than 200 hospitals and drugstores nationwide. The company has also participated in government procurement processes aimed at widening access to critical care products for indigent patients.

Strategic collaborations with local pharmaceutical leaders, including Unilab, reflect a hybrid model that balances commercial growth with public health objectives.

The selection of Centuria Medical Makati as Biocare’s new corporate base carries both strategic and symbolic weight. Situated within Century City in Makati’s central business district, the building is positioned as one of the country’s largest outpatient-focused medical hubs, designed to support integrated preventive and ambulatory care services.

By relocating to a purpose-built medical complex, Biocare signals its intent to align more closely with evolving healthcare delivery models that prioritize accessibility, efficiency, and outpatient-centered systems.

Executives describe the move as more than a change of address. The expanded office is expected to enhance operational coordination, facilitate closer engagement with healthcare partners, and support a growing workforce in an environment built around modern medical infrastructure.

The company reiterates that its long-term objective remains consistent: to deliver cost-effective, globally compliant products that strengthen the Philippine healthcare system while positioning itself as a preferred partner for patients and healthcare professionals.

As Biocare enters its 15th year of operations, the Makati inauguration stands as both validation and forward signal. Validation of a growth trajectory built on regulatory discipline, strategic partnerships, and expanding access—and a forward signal of deeper Indo–Philippine cooperation anchored in healthcare, where diplomatic ties increasingly translate into measurable improvements in patient care.

Leave a Reply